Average Co-Inventor Count = 8.52
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sierra Oncology, Inc. (3 from 4 patents)
2. Gilead Sciences, Inc. (2 from 924 patents)
3. Glaxosmithkline LLC (1 from 356 patents)
4. Thornhill Therapeutics, Inc. (0 patent)
6 patents:
1. RE50497 - (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
2. RE49445 - N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
3. RE48285 - N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
4. 10245268 - Treatment of ACVR1-mediated diseases
5. 9809559 - (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
6. 9469613 - (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide